Design of vitamin E d-α-Tocopheryl Polyethylene Glycol 1000 Succinate-Emulsified Poly (D,L–Lactide–co-Glycolide) Nanoparticles: Influence of Duration of Ultrasonication Energy

The aim of this research was to investigate the effect of the duration of ultrasonication energy on the physicochemical characteristics of the nano-sized particulate drug delivery systems. For this purpose, meloxicam-loaded vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS)-emulsified poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles were designed by using ultrasonication-solvent evaporation technique and were characterized by photon correlation spectroscopy for size and size distribution, scanning electron microscopy for surface morphology and laser Doppler anemometry for surface charge. Ultraviolet -spectrophotometer was used to measure the drug encapsulation efficiency and to obtain in vitro drug release profile. The results showed that the physicochemical properties of the prepared nanoparticles are effectively controlled by the amount of shear stress transferred from the energy source to the emulsion, which is strongly correlated to the ultrasonication time.

[1]  Hanne Mørck Nielsen,et al.  Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. , 2010, International journal of pharmaceutics.

[2]  J. Kristl,et al.  High celecoxib-loaded nanoparticles prepared by a vibrating nozzle device , 2009, Journal of microencapsulation.

[3]  Xiangrong Song,et al.  PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. , 2008, International journal of pharmaceutics.

[4]  C. Hascicek,et al.  Microsphere-based once-daily modified release matrix tablets for oral administration in angina pectoris. , 2008, Journal of microencapsulation.

[5]  S. Lesieur,et al.  Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation. , 2007, International journal of pharmaceutics.

[6]  S. Siegel,et al.  Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. , 2007, International journal of pharmaceutics.

[7]  T. Baykara,et al.  Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration. , 2007, International journal of pharmaceutics.

[8]  Si-Shen Feng,et al.  The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. , 2006, Biomaterials.

[9]  P. McCarron,et al.  Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure , 2006, Journal of microencapsulation.

[10]  Si-Shen Feng,et al.  Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. , 2006, Biomaterials.

[11]  Rubiana M Mainardes,et al.  PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. , 2005, International journal of pharmaceutics.

[12]  M. Wheatley,et al.  Development and characterization of a nano-scale contrast agent. , 2004, Ultrasonics.

[13]  S. Feng,et al.  A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. , 2003, Journal of controlled release : official journal of the Controlled Release Society.